Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy
Clinical trial NCT04040075 · TERMINATED
Trial details
- NCT number
- NCT04040075
- Sponsor
- Southampton Healthcare, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2022-06-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.